iPSC & Stem Cell Culture — Serum and Xeno-Free Media Selection Guide
Induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) are the foundation of disease modelling, drug screening, and cell therapy manufacturing. iPSC technology is converging with CAR-T and gene therapy — iPSC-derived CAR-T cells offer the prospect of off-the-shelf allogeneic cell therapy at industrial scale. Every stem cell programme requires carefully selected serum or serum-free supplements — the wrong grade compromises pluripotency, introduces xenogenic contamination, or fails to support directed differentiation.
Serum Requirements by Stem Cell Application
| Application | Recommended Product | Why |
|---|---|---|
| ESC / iPSC maintenance on feeder cells | FBS ES Cell Pre-Tested — 15–20% in DMEM/F12 or KnockOut DMEM | Lot-tested for pluripotency maintenance — Oct4, Sox2, Nanog expression retained. Spontaneous differentiation rate <5%. Colony morphology validated. |
| MEF feeder cell preparation | FBS ES Cell Pre-Tested — 10% for MEF expansion before mitomycin C inactivation | Consistent feeder cell quality requires consistent FBS — ES Cell Pre-Tested grade ensures MEF morphology and support function reproducibility. |
| Feeder-free iPSC culture (mTeSR, E8) | Serum-free defined medium — rHSA Premium Grade as albumin supplement if required | Modern feeder-free protocols use chemically defined media. rHSA provides albumin without donor variability for xeno-free systems. |
| Embryoid body (EB) formation | FBS ES Cell Pre-Tested — 20% in IMDM or DMEM | EB formation requires serum for spontaneous multi-lineage differentiation. ES Cell Pre-Tested grade provides defined starting conditions. |
| Hematopoietic differentiation | FBS ES Cell Pre-Tested or Donor Horse Serum (DHS) | DHS is used in specific hematopoietic colony-forming assays (CFU-GM, BFU-E) where horse serum provides optimal cytokine-independent support for myeloid differentiation. |
| Neural differentiation | Serum-free (N2/B27 supplements) ± rHSA | Neural differentiation protocols are serum-free — serum drives astrocyte differentiation and blocks neuronal specification. rHSA as protein stabiliser only. |
| Cardiac differentiation (cardiomyocytes) | FBS ES Cell Pre-Tested — 20% in early EB stage; serum-free from day 5 onwards | CHIR99021/Wnt activation protocol requires defined serum conditions in early stage. Serum-free from day 5 for cardiomyocyte specification. |
| iPSC-CAR-T manufacturing | Human Serum AB Male OTC for T cell expansion stage | iPSC-derived T cells require human serum for final expansion and activation — same requirements as primary CAR-T manufacturing. |
| GMP iPSC manufacturing | Xeno-free serum-free + rHSA Premium Grade | Regulatory standard for clinical-grade iPSC products — no animal-derived components. rHSA provides defined albumin supplementation. |
FBS ES Cell Pre-Tested — What Makes It Different
| Parameter | Standard FBS | FBS ES Cell Pre-Tested |
|---|---|---|
| Pluripotency testing | Not tested | ✅ Oct4, Sox2, Nanog expression validated per lot |
| Spontaneous differentiation rate | Variable — can be >20% per passage | ≤5% per passage — lot specification |
| Colony morphology | Not assessed | ✅ Compact colony morphology validated |
| Growth factor profile | Undefined | Lot-selected for LIF-independent pluripotency support |
| Endotoxin | Variable | Low endotoxin — LPS drives differentiation |
| Batch reservation | Standard | ✅ Extended reservation — multi-year iPSC programmes |
Donor Horse Serum (DHS) for Hematopoietic Assays
Donor Horse Serum collected from adult horses via regular donation (not terminal bleed) is the standard supplement for hematopoietic colony-forming unit (CFU) assays and myeloid differentiation protocols. DHS provides a unique growth factor and lipid composition that supports erythroid and myeloid progenitor expansion in ways that FBS cannot replicate.
| Application | DHS Concentration | Protocol |
|---|---|---|
| CFU-GM assay (myeloid progenitors) | 15–30% in methylcellulose medium | Standard StemCell Technologies MethoCult protocol — DHS is specified as the serum source |
| BFU-E assay (erythroid progenitors) | 15–30% in methylcellulose | Erythropoietin-stimulated BFU-E colony formation — DHS provides lipid factors for haemoglobin synthesis |
| iPSC hematopoietic differentiation | 10–20% in differentiation medium | Stage-specific use during myeloid specification from iPSC-derived hemogenic endothelium |
| Bone marrow stromal cell support | 10–15% in stromal culture medium | MSC and stromal cell maintenance for hematopoietic support co-culture systems |
rHSA for Xeno-Free and GMP Stem Cell Protocols
Recombinant Human Serum Albumin (rHSA) is the critical protein supplement for xeno-free and chemically defined stem cell culture systems — replacing animal-derived albumin with a defined, lot-consistent alternative.
| Application | rHSA Concentration | Function |
|---|---|---|
| Xeno-free iPSC maintenance medium | 0.5–2 mg/mL | Albumin carrier for lipids and fatty acids required for stem cell proliferation — replaces bovine albumin in defined media |
| GMP iPSC cryopreservation | 4–10% in cryopreservation medium | Protein cryoprotectant — replaces FBS in xeno-free freezing protocols |
| Feeder-free culture medium supplement | 0.1–1 mg/mL | Stabilises growth factors and protects cells from oxidative stress during culture |
| iPSC-CAR-T expansion medium | 2–5 mg/mL | Albumin supplement in serum-free T cell expansion medium for clinical-grade iPSC-derived CAR-T products |
Frequently Asked Questions
Why can standard FBS not be used for ESC/iPSC culture?
Standard FBS contains undefined factors — particularly BMP signalling activators — that drive spontaneous differentiation of ESCs and iPSCs. Lot-to-lot variability in these factors means that some FBS lots are incompatible with pluripotency maintenance. FBS ES Cell Pre-Tested lots are individually screened for their ability to maintain Oct4, Sox2, and Nanog expression and compact colony morphology — only lots that pass these criteria are released for ES cell applications.
When is Donor Horse Serum preferred over FBS for stem cell applications?
DHS is specifically required for hematopoietic colony-forming unit (CFU) assays using methylcellulose-based media — the published protocols from StemCell Technologies and standard haematology laboratories specify DHS at 15–30% as the serum source. FBS does not provide equivalent support for BFU-E and CFU-GM colony formation. For all other stem cell applications, FBS ES Cell Pre-Tested is the appropriate grade.
What is the difference between rHSA Premium Grade and rHSA Economy Grade?
rHSA Premium Grade is produced in Oryza sativa (rice) expression system — highest purity, lowest endotoxin, validated for GMP stem cell and cell therapy manufacturing. rHSA Economy Grade is produced in Saccharomyces cerevisiae — suitable for research applications and process development where GMP documentation is not required. For clinical-grade iPSC manufacturing, Premium Grade is the correct specification.
Related Applications
| Application | Link |
|---|---|
| CAR-T Cell Manufacturing | CAR-T Manufacturing Guide → |
| Organoid & 3D Cell Culture | Organoid & 3D Culture Guide → |
| FBS ES Cell Pre-Tested product page | FBS ES Cell Pre-Tested → |
Technical enquiries, GMP documentation: info@seamlessbio.de | +49 851 37932226